• admin@ataxiatelangiectasia.es
Ataxia Telangiectasia
  • Home
  • Bibliography
    • Authors
    • Cells and molecules
    • Clinical
    • Country
    • Diseases
    • Drugs
    • Experimental
    • Journals
    • Methods
    • Year
  • Resources
  • What is A-T?
  • News

Bibliography

  • Newborn screening for SCID identifies patients with ataxia telangiectasia.
    Hits: 916
    • primary immunodeficiency
    • United States of America
    • 2013
    • J Clin Immunol
    • Mallott J
    • Kwan A
    • Church J
    • Gonzalez-Espinosa D
    • Lorey F
    • Tang LF
    • Sunderam U
    • Rana S
    • Srinivasan R
    • Brenner SE
    • Puck J
    • SCID
    • screening
    J Clin Immunol. 2013 Apr;33(3):540-9. doi: 10.1007/s10875-012-9846-1. Epub 2012 Dec 20.
    Mallott J1, Kwan A, Church J, Gonzalez-Espinosa D, Lorey F, Tang LF, Sunderam U, Rana S, Srinivasan R, Brenner SE, Puck J.

    Author information

    1
    Department of Pediatrics, University of California San Francisco, San Francisco, CA 94143-0519, USA.

    Abstract

    PURPOSE:

    Severe combined immunodeficiency (SCID) is characterized by failure of T lymphocyte development and absent or very low T cell receptor excision circles (TRECs), DNA byproducts of T cell maturation. Newborn screening for TRECs to identify SCID is now performed in several states using PCR of DNA from universally collected dried blood spots (DBS). In addition to infants with typical SCID, TREC screening identifies infants with T lymphocytopenia who appear healthy and in whom a SCID diagnosis cannot be confirmed. Deep sequencing was employed to find causes of T lymphocytopenia in such infants.

    METHODS:

    Whole exome sequencing and analysis were performed in infants and their parents. Upon finding deleterious mutations in the ataxia telangiectasia mutated (ATM) gene, we confirmed the diagnosis of ataxia telangiectasia (AT) in two infants and then tested archival newborn DBS of additional AT patients for TREC copy number.

    RESULTS:

    Exome sequencing and analysis led to 2 unsuspected gene diagnoses of AT. Of 13 older AT patients for whom newborn DBS had been stored, 7 samples tested positive for SCID under the criteria of California's newborn screening program. AT children with low neonatal TRECs had low CD4 T cell counts subsequently detected (R = 0.64).

    CONCLUSIONS:

    T lymphocytopenia in newborns can be a feature of AT, as revealed by TREC screening and exome sequencing. Although there is no current cure for the progressive neurological impairment of AT, early detection permits avoidance of infectious complications, while providing information for families regarding reproductive recurrence risks and increased cancer risks in patients and carriers.

    PMID:
     
    23264026
     
    PMCID:
     
    PMC3591536
     
    DOI:
     
    10.1007/s10875-012-9846-1
    [Indexed for MEDLINE] 
    Free PMC Article
  • Classical ataxia telangiectasia patients have a congenitally aged immune system with high expression of CD95.
    Hits: 917
    • United Kingdom
    • 2012
    • Taylor AMR
    • Immunology
    • Srinivasan V
    • Carney EF
    • Moss PA
    • J Immunol
    • CD95
    • IL-7
    J Immunol. 2012 Jul 1;189(1):261-8. doi: 10.4049/jimmunol.1101909. Epub 2012 May 30.
    Carney EF1, Srinivasan V, Moss PA, Taylor AM.

    Author information

    1
    School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.

    Abstract

    Ataxia-telangiectasia (A-T) is a rare neurodegenerative immunodeficiency disorder caused by mutations in the ataxia telangiectasia mutated gene. Patients commonly have lymphopenia and Ig-production abnormalities. We used multicolor flow cytometry and IL-7 ELISA to investigate the effect of A-T and age on the proportions of major lymphocyte subsets and their pattern of CD95 expression in relation to IL-7 levels in 15 classical A-T patients. We also analyzed the sensitivity of T cells from four classical A-T patients to CD95-mediated apoptosis using TUNEL and caspase-activation assays. Our results confirmed lymphopenia and a deficiency in naive T and B cells in A-T patients. In contrast to controls, the proportions of naive and memory T and B cell subsets in A-T patients did not vary in relation to age. There was no evidence of a deficiency in plasma IL-7 or IL-7R expression, and IL-7 concentration correlated positively with CD95 expression on CD4(+) T cells. CD95 expression on unstimulated A-T lymphocytes was high, and the apoptotic sensitivity of activated naive and central memory T cells was increased. These findings show that the immunodeficiency in A-T patients may be described as congenitally aged and is not progressive. The naive cell deficiency is not related to a deficiency in IL-7 or its receptor. However, IL-7 may upregulate CD95 on A-T lymphocytes. High CD95 expression and increased apoptotic sensitivity of activated naive and central memory T cells may result in an increased level of CD95-mediated apoptosis, which could contribute to the congenital lymphopenia in A-T.

    PMID:
     
    22649200
     
    DOI:
     
    10.4049/jimmunol.1101909
    [Indexed for MEDLINE] 
    Free full text
  • Dysgerminoma in a child with ataxia-telangiectasia.
    Hits: 1039
    • Turkey
    • case
    • 2007
    • Pediatr Hematol Oncol_
    • Koksal Y
    • Caliskan U
    • Ucar C
    • Yurtcu M
    • Artac H
    • Ilerisoy-Yakut Z
    • Reisli I
    • Dysgerminoma
    Pediatr Hematol Oncol. 2007 Sep;24(6):431-6.
    Koksal Y1, Caliskan U, Ucar C, Yurtcu M, Artac H, Ilerisoy-Yakut Z, Reisli I.

    Author information

    1
    Selcuk University, Meram Faculty of Medicine, Department of Pediatric Oncology, Konya, Turkey. yavuzkoksal@yahoo.com

    Abstract

    Ataxia-telangiectasia is an autosomal recessive disease characterized by progressive cerebellar ataxia, oculocutaneous telangiectasia, immunodeficiency, high incidence of cancer, and increased sensitivity to ionizing radiation. The authors report a case of dysgerminoma in a child with high alpha-fetoprotein, CA125 and beta-human chorionic gonadotropin, who has been followed-up for ataxia-telangiectasia for 2 years.

    PMID:
     
    17710660
     
    DOI:
     
    10.1080/08880010701451434
    [Indexed for MEDLINE]
  • Cancer in ataxia-telangiectasia patients.
    Hits: 934
    • cancer
    • review
    • Cancer Genet Cytogenet
    • 1990
    • Hecht F
    • Hecht BK
    Cancer Genet Cytogenet. 1990 May;46(1):9-19.
    Hecht F1, Hecht BK.

    Author information

    1
    Genetics Center and Cancer Center of Genetrix, Inc., Scottsdale, Arizona.

    Abstract

    A gene locus for ataxia-telangiectasia (A-T) is in chromosome region 11q22 to 11q23 and predisposes to cancer. Ataxia-telangiectasiapatients appear to have two separate clinical patterns of malignancy. One pattern involves solid tumors, which have not been stressed and which include malignancies in the oral cavity, breast, stomach, pancreas, ovary, and bladder. Detection of a solid tumor in an A-T patient should serve as a warning. It heralds a markedly elevated risk of another malignancy in that patient. The second pattern of neoplasia in A-T is well recognized and consists of lymphocytic leukemia and non-Hodgkin's lymphoma. These malignancies may relate to immunodeficiency in A-T and to chromosome breakage and rearrangement, which are a feature of A-T. These two patterns of malignancy may be truly separate and reflect different mechanisms of malignancy in A-T, or they may not really be separate but instead reflect a single mechanism of malignancy. The situation in A-T is reminiscent of that in the acquired immunodeficiency syndrome (AIDS), in which Kaposi's sarcoma occurs with mild immunodeficiency and pneumocystis carinii pneumonia occurs with more profound immunodeficiency owing to the human immunodeficiency virus. Next to pulmonary disease, cancer is the leading cause of death in A-T.

    PMID:
     
    2184934
    [Indexed for MEDLINE]
  • The genetic defect in ataxia-telangiectasia.
    Hits: 878
    • ATM
    • Lavin MF
    • Australia
    • Shiloh Y
    • 1997
    • Annu Rev Immunol
    Annu Rev Immunol. 1997;15:177-202.
    Lavin MF1, Shiloh Y.

    Author information

    1
    Queensland Institute of Medical Research, Bancroft Centre, PO Royal Brisbane Hospital, Herston, Australia.

    Abstract

    The autosomal recessive human disorder ataxia-telangiectasia (A-T) was first described as a separate disease entity 40 years ago. It is a multisystem disease characterized by progressive cerebellar ataxia, oculocutaneous telangiectasia, radiosensitivity, predisposition to lymphoid malignancies and immunodeficiency, with defects in both cellular and humoral immunity. The pleiotropic nature of the clinical and cellular phenotype suggests that the gene product involved is important in maintaining stability of the genome but also plays a more general role in signal transduction. The chromosomal instability and radiosensitivity so characteristic of this disease appear to be related to defective activation of cell cycle checkpoints. Greater insight into the nature of the defect in A-T has been provided by the recent identification, by positional cloning, of the responsible gene, ATM. The ATM gene is related to a family of genes involved in cellular responses to DNA damage and/or cell cycle control. These genes encode large proteins containing a phosphatidylinositol 3-kinase domain, some of which have protein kinase activity. The mutations causing A-T completely inactivate or eliminate the ATM protein. This protein has been detected and localized to different subcellular compartments.

    PMID:
     
    9143686
     
    DOI:
     
    10.1146/annurev.immunol.15.1.177
    [Indexed for MEDLINE]
  • Epstein-barr virus-associated extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma) arising in the parotid gland of a child with ataxia telangiectasia.
    Hits: 876
    • United States of America
    • J Pediatr Hematol Oncol
    • 2015
    • case
    • Bennett JA
    • Bayerl MG
    • lymphoma
    • Epstein-barr virus
    J Pediatr Hematol Oncol. 2015 Mar;37(2):e114-7. doi: 10.1097/MPH.0b013e31829f3496.
    Bennett JA1, Bayerl MG.

    Author information

    1
    Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA.

    Abstract

    Hematologic malignancies, in particular T-cell lymphomas/leukemias, are prevalent in patients with ataxia telangiectasia (AT), with most reported cases being clinically aggressive and high grade. Epstein-Barr virus (EBV) is often associated with lymphoid proliferations/neoplasms arising in immunodeficient patients. Reports of low-grade B-cell neoplasms in the ataxia telangiectasia population are extremely rare. Here, we describe a case of EBV-associated extranodal marginal zone lymphoma (mucosa-associated lymphoid tissue lymphoma) of the parotid gland in a 16-year-old boy with AT. In addition, we review the literature of hematologic malignancies in the AT population as well as the occurrence of EBV in mucosa-associated lymphoid tissue lymphoma.

    PMID:
     
    25692616
     
    DOI:
     
    10.1097/MPH.0b013e31829f3496
    [Indexed for MEDLINE]
  • Identification of ATM mutations in Korean siblings with ataxia-telangiectasia.
    Hits: 887
    • 2013
    • ATM mutations
    • Korea
    • Ann Lab Med
    • Huh HJ
    • Cho KH
    • Lee JE
    • Kwon MJ
    • Ki CS
    • Lee PH
    Ann Lab Med. 2013 May;33(3):217-20. doi: 10.3343/alm.2013.33.3.217. Epub 2013 Apr 17.
    Huh HJ1, Cho KH, Lee JE, Kwon MJ, Ki CS, Lee PH.

    Author information

    1
    Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

    Abstract

    Ataxia-telangiectasia (A-T) is a rare autosomal recessive neurodegenerative disorder. It is characterized by early-onset, progressive cerebellar ataxia, oculomotor apraxia, choreoathetosis, conjunctival telangiectasias, immunodeficiency, and an increased risk of malignancy. Although A-T is known to be the most common cause of progressive cerebellar ataxia in childhood, there have been no confirmed cases in Korea. We report the clinical and genetic findings of Korean siblings who presented with limb and truncal ataxia, oculomotor apraxia, choreoathetosis, and telangiectasias of the eyes. Sequence analysis of the ataxia-telangiectasia mutated (ATM) gene revealed a known missense mutation (c.8546G>C; p.Arg2849Pro) and a novel intronic variant of intron 17 (c.2639-19_2639-7del13). Reverse-transcription PCR and sequencing analysis revealed that the c.2639-19_2639-7del13 variant causes a splicing aberration that potentiates skipping exon 18. Because A-T is quite rare in Korea, the diagnosis of A-T in Korean patients can be delayed. We recommend that a diagnosis of A-T should be suspected in Korean patients exhibiting the clinical features of A-T.

    KEYWORDS:

    Ataxia; Ataxia telangiectasia; Ataxia telangiectasia mutated protein; Korea

    PMID:
     
    23667852
     
    PMCID:
     
    PMC3646200
     
    DOI:
     
    10.3343/alm.2013.33.3.217
    [Indexed for MEDLINE] 
    Free PMC Article
  • Twelve novel Atm mutations identified in Chinese ataxia telangiectasia patients.
    Hits: 849
    • China
    • 2014
    • Neuromolecular Med
    • ATM mutations
    • Huang Y
    • Yang L
    • Wang J
    • Yang F
    • Xiao Y
    • Xia R
    • Yuan X
    • Yan M
    Neuromolecular Med. 2013 Sep;15(3):536-40. doi: 10.1007/s12017-013-8240-3. Epub 2013 Jun 27.
    Huang Y1, Yang L, Wang J, Yang F, Xiao Y, Xia R, Yuan X, Yan M.

    Author information

    1
    Department of Medical Genetics, Peking University Health Science Center, Beijing, China.

    Erratum in

    • Neuromolecular Med. 2014 Mar;16(1):216.

    Abstract

    Ataxia telangiectasia (A-T) is an autosomal recessive disease characterized mainly by progressive cerebellar ataxia, oculocutaneous telangiectasia, and immunodeficiency. This disease is caused by mutations of the ataxia telangiectasia mutated (Atm) gene. More than 500 Atm mutations that are responsible for A-T have been identified so far. However, there have been very few A-T cases reported in China, and only two Chinese A-T patients have undergone Atm gene analysis. In order to systemically investigate A-T in China and map their Atm mutation spectrum, we recruited eight Chinese A-T patients from six unrelated families nationwide. Using direct sequencing of genomic DNA and the multiplex ligation-dependent probe amplification, we identified twelve pathogenic Atm mutations, including one missense, four nonsense, five frameshift, one splicing, and one large genomic deletion. All the Atm mutations we identified were novel, and no homozygous mutation and founder-effect mutation were found. These results suggest that Atm mutations in Chinese populations are diverse and distinct largely from those in other ethnic areas.

    PMID:
     
    23807571
     
    PMCID:
     
    PMC3732755
     
    DOI:
     
    10.1007/s12017-013-8240-3
    [Indexed for MEDLINE] 
    Free PMC Article
  • Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.
    Hits: 840
    • United Kingdom
    • ATM mutations
    • immunodeficiency
    • Clin Exp Immunol
    • Byrd PJ
    • 2008
    • Davies EG
    • Reiman A
    • McDermott EM
    • Staples ER
    • Ritchie S
    • Taylor AM
    Clin Exp Immunol. 2008 Aug;153(2):214-20. doi: 10.1111/j.1365-2249.2008.03684.x. Epub 2008 May 26.
    Staples ER1, McDermott EM, Reiman A, Byrd PJ, Ritchie S, Taylor AM, Davies EG.

    Author information

    1
    Department of Immunology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.

    Abstract

    Immunodeficiency affects over half of all patients with ataxia telangiectasia (A-T) and when present can contribute significantly to morbidity and mortality. A retrospective review of clinical history, immunological findings, ataxia telangiectasia mutated (ATM) enzyme activity and ATM mutation type was conducted on 80 consecutive patients attending the National Clinic for Ataxia Telangiectasia, Nottingham, UK between 1994 and 2006. The aim was to characterize the immunodeficiency in A-T and determine its relationship to the ATM mutations present. Sixty-one patients had mutations resulting in complete loss of ATM kinase activity (group A) and 19 patients had leaky splice or missense mutations resulting in residual kinase activity (group B). There was a significantly higher proportion of patients with recurrent sinopulmonary infections in group A compared with group B (31 of 61 versus four of 19 P = 0.03) and a greater need for prophylactic antibiotics (30 of 61 versus one of 19 P = 0.001). Comparing group A with group B patients, 25 of 46 had undetectable/low immunoglobulin A (IgA) levels compared with none of 19; T cell lymphopenia was found in 28 of 56 compared with one of 18 and B cell lymphopenia in 35 of 55 compared with four of 18 patients (P = 0.00004, 0.001 and 0.003 respectively). Low IgG2 subclass levels and low levels of antibodies to pneumococcal polysaccharide were more common in group A than group B (16 of 27 versus one of 11 P = 0.01; 34/43 versus six of 17 P = 0.002) patients. Ig replacement therapy was required in 10 (12.5%) of the whole cohort, all in group A. In conclusion, A-T patients with no ATM kinase activity had a markedly more severe immunological phenotype than those expressing low levels of ATM activity.

    PMID:
     
    18505428
     
    PMCID:
     
    PMC2492895
     
    DOI:
     
    10.1111/j.1365-2249.2008.03684.x
    [Indexed for MEDLINE] 
    Free PMC Article
  • Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.
    Hits: 843
    • ataxia telangiectasia
    • 2013
    • J Neurol Sci
    • ATM mutations
    • Senataxin
    • Davis MY
    • Keene CD
    • Swanson PD
    • Sheehy C
    • Bird TD
    • AOA2
    • SETX
    • Ataxia oculomotor apraxia type 2
    J Neurol Sci. 2013 Dec 15;335(1-2):134-8. doi: 10.1016/j.jns.2013.09.014. Epub 2013 Sep 17.
    Davis MY1, Keene CD, Swanson PD, Sheehy C, Bird TD.

    Author information

    1
    Department of Neurology, University of Washington, Seattle, WA, United States.

    Abstract

    Ataxia telangiectasia (AT) and ataxia oculomotor apraxia type 2 (AOA2) are autosomal recessive ataxias caused by mutations in genes involved in maintaining DNA integrity. Lifespan in AT is greatly shortened (20s-30s) due to increased susceptibility to malignancies (leukemia/lymphoma). Lifespan in AOA2 is uncertain. We describe a woman with variant AT with two novel mutations in ATM (IVS14+2T>G and 5825C>T, p.A1942V) who died at age 48 with pancreatic adenocarcinoma. Her mutations are associated with an unusually long life for AT and with a cancer rarely associated with that disease. We also describe two siblings with AOA2, heterozygous for two novel mutations in senataxin (3 bp deletion c.343-345 and 1398T>G, p.I466M) who have survived into their 70s, allowing us to characterize the longitudinal course of AOA2. In contrast to AT, we show that persons with AOA2 can experience a prolonged lifespan with considerable motor disability.

    KEYWORDS:

    AOA2; AT; ATM; Ataxia; Ataxia oculomotor apraxia type 2; Ataxia telangiectasia; SETX; Senataxin

    PMID:
     
    24090759
     
    PMCID:
     
    PMC4017341
     
    DOI:
     
    10.1016/j.jns.2013.09.014
    [Indexed for MEDLINE] 
    Free PMC Article
  • Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients.
    Hits: 905
    • Iran
    • Aghamohammadi A
    • Rezaei N
    • Pediatr Neurol
    • 2007
    • Moin M
    • Kouhi A
    • Tavassoli S
    • Ghaffari SR
    • Gharagozlou M
    • Movahedi M
    • Purpak Z
    • Mirsaeid Ghazi B
    • Mahmoudi M
    • Farhoudi A
    Pediatr Neurol. 2007 Jul;37(1):21-8.
    Moin M1, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari SR, Gharagozlou M, Movahedi M, Purpak Z, Mirsaeid Ghazi B, Mahmoudi M, Farhoudi A.

    Author information

    1
    Department of Allergy and Clinical Immunology, Children's Medical Center, and Immunology, Asthma and Allergy Research Institute, Tehran, Iran.

    Abstract

    Ataxia-telangiectasia is a multisystem disorder characterized by progressive neurologic impairment, variable immunodeficiency, impaired organ maturation, x-ray hypersensitivity, oculocutaneous telangiectasia, and a predisposition to malignancy. To evaluate clinical and immunologic features of Iranian patients with ataxia-telangiectasia, the records of 104 patients with ataxia-telangiectasia (54 male, 50 female) with the age range of 1.6-23.5 years were reviewed. The Iranian Primary Immunodeficiency Registry was used as the data source. Progressive ataxia was seen in all the patients. Other symptoms were eye movement disorders (n = 84), slurred speech (n = 70), mental retardation (n = 10), and ocular (n = 87) and cutaneous (n = 73) telangiectasia. Three patients developed leukemia and lymphoma, and 17 patients had family history of malignancy. Positive correlation was seen between clinical immunologic symptoms and immunoglobulin deficiencies (P = 0.004). The predominant infections were sinopulmonary and acute and recurrent infections (78 cases). Infections included pneumonia (56 patients), otitis media (34 patients), and sinusitis (50 patients). Average serum alpha-fetoprotein level was 149 +/- 137 ng/dL. The incidence of ataxia-telangiectasia in Iran is high, possibly due to familial marriages. Treatment should be focused on supportive management to prolong survival.

    PMID:
     
    17628218
     
    DOI:
     
    10.1016/j.pediatrneurol.2007.03.002
    [Indexed for MEDLINE]
  • Non-hodgkin B-cell lymphoma of the ovary in a child with Ataxia-telangiectasia.
    Hits: 851
    • United States of America
    • 2013
    • case
    • J Pediatr Adolesc Gynecol
    • Danby CS
    • Allen L
    • Moharir MD
    • Weitzman S
    • Non-hodgkin B-cell lymphoma
    • ovary
    J Pediatr Adolesc Gynecol. 2013 Apr;26(2):e43-5. doi: 10.1016/j.jpag.2012.09.003. Epub 2013 Jan 9.
    Danby CS1, Allen L, Moharir MD, Weitzman S, Dumont T.

    Author information

    1
    Department of Obstetrics and Gynecology, Maine Medical Center, Portland, ME, USA.

    Abstract

    BACKGROUND:

    Ataxia-telangiectasia is a multisystem, life-limiting, recessively inherited genetic disorder caused by mutations in the Ataxia-telangiectasia mutated gene. It is characterized by the onset of changes in neurological and immunological development, organ maturation in childhood, as well as a high incidence of malignancies.

    CASE:

    We describe a case of an 11-year-old girl with a history of progressive ataxia and new finding of bilateral pelvic masses. Given an elevated alpha-fetoprotein, the pre-operative working diagnosis was a malignant germ cell tumor. Final ovarian pathology revealed a non-Hodgkin B-cell lymphoma with Burkitt-like morphology.

    SUMMARY:

    We present the first case of a primary ovarian non-Hodgkin B-cell lymphoma in a child with Ataxia-telangiectasia.

    Copyright © 2013 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

    PMID:
     
    23312583
     
    DOI:
     
    10.1016/j.jpag.2012.09.003
    [Indexed for MEDLINE]
  • Ataxia telangiectasia: report of two cases.
    Hits: 848
    • case
    • Taiwan
    • 2001
    • J Microbiol Immunol Infect
    • Huang KY
    • Shyur SD
    • Wang CY
    • Shen EY
    • Liang DC
    J Microbiol Immunol Infect. 2001 Mar;34(1):71-5.
    Huang KY1, Shyur SD, Wang CY, Shen EY, Liang DC.

    Author information

    1
    Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan, ROC.

    Abstract

    Ataxia telangiectasia (A-T) is a rare autosomal recessive multisystem disease. The diagnosis of A-T is based on the typical clinical picture: ataxia and telangiectasia. However, an increase in (alpha-fetoprotein (AFP) level and the identification of the A-T mutated gene (ATM) assist in an early diagnosis. Here we report two cases of A-T diagnosed in our hospital (case 1: a 7-year-old boy; case 2: an 8-year-old girl). Both of these patients had typical clinical pictures of ataxia and telangiectasia, AFP was also increased (case 1:471.2 ng/dL; case 2: 196 ng/dL). T-cell dysfunction was noted in both patients. Case 1 had IgG2 deficiency and case 2 had IgA, IgG2 and IgG3 deficiency. Case 2 developed malignant lymphoma at 9 years of age and died of pneumonia with respiratory failure at 10 years of age. Because of rhe rarity of A-T in Taiwan, we report two cases to help pediatricians make an early diagnosis of A-T if they have a patient with progressive ataxia and oculocutaneous telangiectasia.

    PMID:
     
    11321131
    [Indexed for MEDLINE]
  • Different clinical and laboratory evolutions in ataxia-telangiectasia syndrome: report of four cases.
    Hits: 808
    • Brazil
    • Allergol Immunopathol (Madr)
    • case
    • 2005
    • Forte WC
    • Menezes MC
    • Dionigi PC
    • Bastos CL
    Allergol Immunopathol (Madr). 2005 Jul-Aug;33(4):199-203.
    Forte WC1, Menezes MC, Dionigi PC, Bastos CL.

    Author information

    1
    Immunology Section, Santa Casa Medical School and Hospital, São Paulo, Brazil. wilmanevesforte@yahoo.com.br

    Abstract

    We report four patients with ataxia-telangiectasia syndrome that presented varied neurologic evolution. Three patients initially presented neurologic alterations of slow progression, evolving to late immunocompromised conditions. The fourth patient presented, from symptom onset, immune and neurologic debilitation, that were both severe and of fast progression. The chronological sequence of the most commonly observed immunocompromised conditions were in our patients, in ascending order, IgA deficiency, IgG2 deficiency and the neutrophil phagocytosis stage and common variable immunodeficiency. The first two reports are of sisters in whom the diagnosis was done between the ages of three and six years, having ocular apraxia, cerebellar ataxia and telangiectasia. Slow progression of neurologic debilitation was observed, without presentation of intermittent infections. The patients began presenting accentuated immunocompromised conditions at the ages of 14 and 17 years, dying at the ages of 16 and 20 years, respectively, due to severe infections that were resistant to treatment. The diagnosis of the third case was established when the patient was two years old, presenting ataxia and telangiectasia. Syndrome progression was slow, presenting at the age of eight years more accentuated neurologic disorders and IgA deficiency. The fourth case presented significant neurologic compromise at the age of five, simultaneous to IgA and IgG2 deficiency, and repeating pneumonias and sinusitis. At this time, intravenous gammaglobulin reposition was done. The neurologic and immune disorders progressed rapidly, and at the age of eight presented the inability to walk. At this time inversion of the CD4/CD8 ration was verified through laboratory tests.

  • Unusual absence of neurologic symptoms in a six-year old girl with ataxia-telangiectasia.
    Hits: 891
    • case
    • 2004
    • J Postgrad Med
    • Trimis GG
    • Athanassaki CK
    • Kanariou MM
    • Giannoulia-Karantana AA
    • Greece
    J Postgrad Med. 2004 Oct-Dec;50(4):270-1.
    Trimis GG1, Athanassaki CK, Kanariou MM, Giannoulia-Karantana AA.

    Author information

    1
    Pediatric Department of University of Athens, Greece. gtrim@lycos.co.uk

    Abstract

    Ataxia-telangiectasia (A-T) is a rare multisystem, neurodegenerative genetic disorder. We present a case of a 6-year-old girl who had a history of frequent respiratory infections and also had ocular and immunological features of this syndrome. The absence of neurological symptoms, which is very unusual for a patient of this age, raised many difficulties in the diagnosis of the disease. It is concluded that a normal neurological assessment must not exclude the diagnosis of A-T and delay the proper interventional measures.

    PMID:
     
    15623968
    [Indexed for MEDLINE] 
    Free full text
  • Autoimmune hemolytic anemia in a patient with probable ataxia telangiectasia: a case report.
    Hits: 849
    • Iran
    • 2014
    • case
    • Iran J Immunol
    • Alyasin S
    • Khoshkhui M
    • Abolnezhadian F
    • Autoimmune hemolytic anemia
    Iran J Immunol. 2014 Sep;11(3):217-20. doi: IJIv11i3A8.
    Alyasin S1, Khoshkhui M, Abolnezhadian F.

    Author information

    1
    Allergy Research Center, Shiraz university of medical science, Shiraz, Iran, alyasins@sums.ac.ir.

    Abstract

    BACKGROUND:

    Ataxia telangiectasia (AT) is one of the combined immunodeficiency syndromes with immunologic, neurologic, endocrinologic, hepatic and cutaneous abnormalities. Regarding the fact that autoimmune disorders; such as autoimmune hemolytic anemia (AIHA), are not generally expected in the course of AT, we present a patient with an unusual presentation of these two conditions.

    CASE PRESENTATION:

    An otherwise seemingly normal girl, who had developed limping at the age of 11 months old, referred to Namazi Hospital, Shiraz, Iran, due to pallor and latitude at the age of 3 yrs and was diagnosed of AIHA. After 2 years of therapeutic course she developed ocular telangiectasia and ataxic gate.

    CONCLUSION:

    This case emphasizes on the possibility of ataxia telangiectasia coexistence with autoimmune disorders that must be taken into consideration by physicians.

    PMID:
     
    25265999
     
    DOI:
     
    IJIv11i3A8
    [Indexed for MEDLINE] 
    Free full text
  • Autonomic dysfunction in patients with Ataxia-Telangiectasia.
    Hits: 764
    • 2006
    • Clin Neurophysiol
    • Tubani L
    • Donato G
    • Perciaccante A
    • Baratta L
    • Fiorentini A
    • Fiorilli M
    • Autonomic dysfunction
    Clin Neurophysiol. 2006 Jul;117(7):1630-1. Epub 2006 Jun 6.
    Tubani L, Donato G, Perciaccante A, Baratta L, Fiorentini A, Fiorilli M.
    PMID:
     
    16753332
     
    DOI:
     
    10.1016/j.clinph.2006.02.026
    [Indexed for MEDLINE]
  • Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation.
    Hits: 895
    • United States of America
    • Poland
    • J Pediatr Hematol Oncol
    • 2010
    • Pietrucha B
    • Heropolitanska-Pliszka E
    • Bernatowska E
    • Gatti RA
    • hyper IgM syndrome
    • Wilms tumor
    • Wakulińska A
    • Skopczyńska H

    J Pediatr Hematol Oncol. 2010 Jan;32(1):e28-30. doi: 10.1097/MPH.0b013e3181bfd3d9.

    Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation.

    Pietrucha BM1, Heropolitańska-Pliszka E, Wakulińska A, Skopczyńska H, Gatti RA, Bernatowska E.

    Author information

    1
    Department of Immunology, The Children's Memorial Health Institute, Warsaw, Poland. barbara.p@rocketmail.com

    Abstract

    Ataxia-telangiectasia is an autosomal recessive disorder caused by mutation in the ATM gene. Hallmarks of the disease comprise progressive cerebellar ataxia, oculocutaneous telangiectasiae, cancer susceptibility, and variable humoral and cellular immunodeficiency. We report a patient who, because of the pattern of her immunodeficiency, was primarily diagnosed as an autosomal recessive hyper-IgM syndrome. Only a mild cerebellar ataxia was present at the age of 7 years then she developed a Wilms tumor (nephroblastoma). Conventional radiotherapy for the malignancy led to fatal consequences. Postmortem studies confirmed diagnosis of ataxia-telangiectasia.

    PMID:
     
    20051774
     
    DOI:
     
    10.1097/MPH.0b013e3181bfd3d9
    [Indexed for MEDLINE]
  • Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia.
    Hits: 878
    • Germany
    • 2012
    • case
    • Hyper IGM phenotype
    • J Clin Immunol
    • Ghosh S
    • Borkhardt A
    • Schuster FR
    • Binder V
    • Baldus SE
    • Seiffert P
    • Laws HJ
    • Meisel R
    • allogeneic stem cell transplantation
    J Clin Immunol. 2012 Jun;32(3):438-40. doi: 10.1007/s10875-012-9654-7. Epub 2012 Feb 23.
    Ghosh S1, Schuster FR, Binder V, Niehues T, Baldus SE, Seiffert P, Laws HJ, Borkhardt A, Meisel R.

    Author information

    1
    Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine Universität Düsseldorf, Medical Faculty, 40225, Düsseldorf, Germany. sujal.ghosh@med.uni-duesseldorf.de

    Abstract

    Allogeneic hematopoietic stem cell transplantation (HSCT) has not been a therapeutic option in ataxia telangiectasia (AT) due to overwhelming toxicity of conditioning in the context of the global DNA repair deficiency. Furthermore HSCT is unable to cure neurological involvement of AT. We report on a Turkish child with a Hyper IgM phenotype disorder, in which clinical aspects of AT were absent and thus, AT not diagnosed. He was transplanted with a reduced toxicity, but full intensity conditioning regimen comprising treosulfan, fludarabine and ATG. The peritransplant period was uneventful and the patient was discharged at day +57. 8 months after HSCT, the patient developed hepatopathy with monoclonal gammopathy of unclear significance and died due to hepatic failure and encephalopathy at the age of 32 months. Post mortem high throughput sequencing revealed a mutation in the ATM gene.

    PMID:
     
    22354567
     
    DOI:
     
    10.1007/s10875-012-9654-7
    [Indexed for MEDLINE]
  • Low thymic output and reduced heterogeneity of alpha/beta, but not gamma/delta, T lymphocytes in infants with ataxia-telangiectasia.
    Hits: 845
    • Italy
    • Micheli R
    • Plebani A
    • Neuropediatrics
    • immunodeficiency
    • 2003
    • Pirovano S
    • Calandra G
    • Valotti M
    • Albertini A
    • Imberti L
    • T lymphocytes
    Neuropediatrics. 2003 Jun;34(3):165-7.
    Micheli R1, Pirovano S, Calandra G, Valotti M, Plebani A, Albertini A, Imberti L.

    Author information

    1
    Pediatric Neuropsychiatry, Spedali Civili of Brescia, Brescia, Italy. limberti@yahoo.it

    Abstract

    Ataxia-telangiectasia, a genetic disease caused by the homozygous mutation of the ATM gene, is frequently associated to a deficit of humoral and cellular immune functions. A decreased thymic output and skewed T cell and B cell receptor repertoires have been recently described in children over 7 years of age and in adults with this disease and have been proposed as a possible explanation for the immunodeficiency. To understand whether T cell defects arise early in life as a consequence of ATM gene mutations, we analysed the extent of thymic function by measuring the number of naïve T cells and by studying the heterogeneity of T cells by means of heteroduplex analysis, in two children less than 2 years old with a remarkable reduction of T cell count. We found that the thymic output is decreased in babies with ataxia-telangiectasia if compared with that observed in age-matched normal babies. The low production of new T cells is associated to a reduction of the diversity of alpha/beta, but not gamma/delta, T lymphocytes. Our data indicate that ATM mutation limits the generation of a wide alpha/beta T cell repertoire and this feature can be responsible for the immunodeficiency observed in ataxia-telangiectasia babies.

    PMID:
     
    12910443
     
    DOI:
     
    10.1055/s-2003-41280
    [Indexed for MEDLINE]

Page 11 of 21

  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15

Language

Select your language

  • Hindi (India)
  • Hebrew
  • Arabic (اللغة العربية)
  • Turkish (Turkey)
  • 日本語 (Japan)
  • Russian (Russia)
  • Français (France)
  • Deutsch (Deutschland)
  • Español (España)
  • Nederlands (nl-NL)
  • Português Brasileiro (pt-BR)
  • Polski (PL)
  • Italiano (Italia)
  • English (United Kingdom)

Tweets by A_Tinfo

  • Sitemap
Ataxia Telangiectasia
  • Home
  • Bibliography
    • Authors
    • Cells and molecules
    • Clinical
    • Country
    • Diseases
    • Drugs
    • Experimental
    • Journals
    • Methods
    • Year
  • Resources
  • What is A-T?
  • News
  • admin@ataxiatelangiectasia.es